Ables, Iannone, Moore & Associates »

Regeneron Pharmaceuticals shares owned by Ables, Iannone, Moore & Associates

Quarter-by-quarter ownership of Regeneron Pharmaceuticals (REGN) shares owned by Ables, Iannone, Moore & Associates from 13F filings

Historical chart of Ables, Iannone, Moore & Associates investment in Regeneron Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Regeneron Pharmaceuticals held by Ables, Iannone, Moore & Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Regeneron Pharmaceuticals by Ables, Iannone, Moore & Associates

Quarter filed Position value Share count Share price at filing
2023-12-31 $2.6k 3 878.33